4.7 Article

Fatal immune dysregulation due to a gain of glycosylation mutation in lymphocyte perforin

Journal

BLOOD
Volume 119, Issue 7, Pages 1713-1716

Publisher

AMER SOC HEMATOLOGY
DOI: 10.1182/blood-2011-08-374355

Keywords

-

Categories

Funding

  1. Cancer Council Victoria
  2. National Health and Medical Research Council of Australia

Ask authors/readers for more resources

Mutations in the perforin gene (PRF1) are a common cause of the fatal immune dysregulation disorder, familial hemophagocytic lymphohistiocytosis (type 2 FHL, FHL2). Here we report a female infant born with biallelic PRF1 mutations: a novel substitution, D49N, and a previously identified in-frame deletion, K285del. We assessed the effects of each mutation on the cytotoxicity of human NK cells in which the expression of endogenous perforin was ablated with miR30-based short hairpin (sh)RNAs. Both mutations were detrimental for function, thereby explaining the clinically severe presentation and rapidly fatal outcome. We demonstrate that D49N exerts its deleterious effect by generating an additional (third) N-linked glycosylation site, resulting in protein misfolding and degradation in the killer cell. Our data provide a rationale for treating some cases of type 2 familial hemophagocytic lymphohistiocytosis, based on the pharmacologic inhibition or modification of glycosylation. (Blood.2012;119(7):1713-1716)

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Editorial Material Infectious Diseases

Effectiveness of BNT162b2 against COVID-19 in adolescents

Annabel A. Powell, Freja Kirsebom, Julia Stowe, Kelsey McOwat, Vanessa Saliba, Mary E. Ramsay, Jamie Lopez-Bernal, Nick Andrews, Shamez N. Ladhani

LANCET INFECTIOUS DISEASES (2022)

Letter Immunology

Effectiveness of COVID-19 Vaccines Against Hospitalization and Death With the SARS-CoV-2 Delta Variant in Solid Organ and Islet Transplant Recipients

Sarah V. Williams, Heather J. Whitaker, Lisa Mumford, Chris Callaghan, Rebecca M. K. Curtis, Julia Stowe, Freja Kirsebom, James Thomas, Ines Ushiro-Lumb, Rommel Ravanan, Jamie Lopez-Bernal

TRANSPLANTATION (2022)

Article Pediatrics

Community seroprevalence of SARS-CoV-2 in children and adolescents in England, 2019-2021

Helen Ratcliffe, K. S. Tiley, Nick Andrews, Gayatri Amirthalingam, I Vichos, E. Morey, N. L. Douglas, S. Marinou, Emma Plested, Parvinder Aley, Eva P. Galiza, Saul N. Faust, S. Hughes, Clare S. Murray, Marion Roderick, Fiona Shackley, Sam J. Oddie, Tim Lees, D. P. J. Turner, M. Raman, Stephen Owens, Paul Turner, H. Cockerill, J. Lopez Bernal, E. Linley, Ray Borrow, Kevin Brown, Mary Elizabeth Ramsay, M. Voysey, Matthew D. Snape

Summary: The objective of this study was to understand the community seroprevalence of SARS-CoV-2 in children and adolescents. The study found that approximately one-third of participants aged 15-18 years old had evidence of antibodies against SARS-CoV-2 prior to the introduction of widespread vaccination. Furthermore, ethnic background was found to be independently associated with the risk of SARS-CoV-2 infection in children.

ARCHIVES OF DISEASE IN CHILDHOOD (2023)

Article Computer Science, Information Systems

Monitoring the COVID-19 immunisation programme through a national immunisation Management system - England's experience

Elise Tessier, Michael Edelstein, Camille Tsang, Freja Kirsebom, Charlotte Gower, Colin N. J. Campbell, Mary Ramsay, Joanne White, Nick Andrews, Jamie Lopez-Bernal, Julia Stowe

Summary: A national vaccine register was established in England to collect data on COVID-19 vaccinations delivered in various settings. The register allows for verification of vaccination records through individual self-reporting. This system has enabled the UK Health Security Agency to estimate vaccine coverage and provide rapid and accurate vaccine effectiveness estimates.

INTERNATIONAL JOURNAL OF MEDICAL INFORMATICS (2023)

Article Infectious Diseases

Protection against symptomatic infection with delta (B.1.617.2) and omicron (B.1.1.529) BA.1 and BA.2 SARS-CoV-2 variants after previous infection and vaccination in adolescents in England, August, 2021-March, 2022: a national, observational, test-negative, case-control study

Annabel A. Powell, Freja Kirsebom, Julia Stowe, Mary E. Ramsay, Jamie Lopez-Bernal, Nick Andrews, Shamez N. Ladhani

Summary: This study aimed to estimate the protection against Delta and Omicron variants in adolescents with previous infection, mRNA vaccination, and hybrid immunity. The findings showed that previous infection provided some protection against subsequent reinfection, and vaccination added to this protection. Hybrid immunity provided the most robust protection. Therefore, the need for additional booster doses for adolescents in populations with already high protection is questioned.

LANCET INFECTIOUS DISEASES (2023)

Article Infectious Diseases

Early evaluation of the safety, reactogenicity, and immune response after a single dose of modified vaccinia Ankara- Bavaria Nordic vaccine against mpox in children: a national outbreak response

Shamez N. Ladhani, Alexander C. Dowell, Scott Jones, Bethany Hicks, Cathy Rowe, Jusnara Begum, Dagmar Wailblinger, John Wright, Stephen Owens, Ailsa Pickering, Benjamin Shilltoe, Paddy Mcmaster, Elizabeth Whittaker, Jianmin Zuo, Annabel Powell, Gayatri Amirthalingam, Sema Mandal, Jamie Lopez-Bernal, Mary E. Ramsay, Neave Kissane, Michael Bell, Heather Watson, David Ho, Bassam Hallis, Ashley Otter, Paul Moss, Jonathan Cohen

Summary: This study assessed the safety, immune response, and reactogenicity of MVA-BN vaccine in children. The results showed that the vaccine induced a robust immune response with no serious adverse events. This supports the use of MVA-BN vaccine for post-exposure prophylaxis in children, but larger studies are needed for further evaluation.

LANCET INFECTIOUS DISEASES (2023)

Article Medicine, General & Internal

Epidemiology of hospitalisations due to chickenpox and quality of life lost in community and hospital settings: protocol for a prospective cohort study across two countries

Robin Marlow, Marion Roderick, Jennifer Oliver, Zoe Jordan, Gayatri Amirthalingam, Jamie Lopez-Bernal, Adam Finn, Fernanda Rodrigues

Summary: This study aims to assess the impact of pediatric chickenpox on quality of life and collect relevant data through observation and survey in the UK and Portugal. The results will be used to estimate the loss of quality-adjusted life years for cases of chickenpox and its complications. The results will be published in peer-reviewed publications.

BMJ OPEN (2023)

Letter Infectious Diseases

Risk of severe outcomes among SARS-CoV-2 Omicron BA.4 and BA.5 cases compared to BA.2 cases in England

Nurin Abdul Aziz, Sophie Grace Nash, Asad Zaidi, Tommy Nyberg, Natalie Groves, Russell Hope, Jamie Lopez Bernal, Gavin Dabrera, Simon Thelwall

JOURNAL OF INFECTION (2023)

Article Infectious Diseases

Duration of protection of ancestral-strain monovalent vaccines and effectiveness of bivalent BA.1 boosters against COVID-19 hospitalisation in England: a test-negative case- control study

Freja Cordelia Moller Kirsebom, Nick Andrews, Julia Stowe, Mary Ramsay, Jamie Lopez Bernal

Summary: This study aims to estimate the long-term duration of protection provided by monovalent COVID-19 vaccines and the incremental vaccine effectiveness of bivalent BA.1 boosters. The study found that monovalent COVID-19 vaccines offer moderate long-term protection against hospitalization in people aged 65 years or older, and that bivalent BA.1 boosters were effective in preventing hospitalization among people aged 50 years or older, especially during the circulation of omicron lineages in England.

LANCET INFECTIOUS DISEASES (2023)

Article Public, Environmental & Occupational Health

Comparative transmission of SARS-CoV-2 Omicron (B.1.1.529) and Delta (B.1.617.2) variants and the impact of vaccination: national cohort study, England

Hester Allen, Elise Tessier, Charlie Turner, Charlotte Anderson, Paula Blomquist, David Simons, Alessandra Lochen, Christopher I. Jarvis, Natalie Groves, Fernando Capelastegui, Joe Flannagan, Asad Zaidi, Cong Chen, Christopher Rawlinson, Gareth J. Hughes, Dimple Chudasama, Sophie Nash, Simon Thelwall, Jamie Lopez-Bernal, Gavin Dabrera, Andre Charlett, Meaghan Kall, Theresa Lamagni

Summary: A study in England compared the transmission differences between the Omicron variant and the Delta variant of SARS-CoV-2. The study found that Omicron had higher secondary attack rates in households (15.0% vs. 10.8%) and non-households (8.2% vs. 3.7%) compared to Delta. The effectiveness of vaccination in reducing transmission risk was lower for Omicron compared to Delta.

EPIDEMIOLOGY AND INFECTION (2023)

Article Immunology

Effects of Second Dose of SARS-CoV-2 Vaccination on Household Transmission, England

Asad Zaidi, Ross Harris, Jennifer Hall, Sarah Woodhall, Nick Andrews, Kevin Dunbar, Jamie Lopez-Bernal, Gavin Dabrera

Summary: A study in England assessed the effects of receiving 2 doses of the SARS-CoV-2 vaccine on household transmission. The study found that contacts of 2-dose vaccinated case-patients had a lower risk of becoming secondary case-patients compared to contacts of unvaccinated case-patients. The reduction of onward transmission varied depending on the vaccine type and the time since the second dose.

EMERGING INFECTIOUS DISEASES (2023)

Article Infectious Diseases

Increased reports of severe myocarditis associated with enterovirus infection in neonates, United Kingdom, 27 June 2022 to 26 April 2023

Anika Singanayagam, Catherine Moore, Susannah Froude, Cristina Celma, Julia Stowe, Erjola Hani, Khuen Foong Ng, Peter Muir, Marion Roderick, Simon Cottrell, David F. Bibby, Barry Vipond, Sophie Gillett, Peter J. Davis, Jack Gibb, Mai Barry, Phillippa Harris, Frances Rowley, Jiao Song, Ananda Giri Shankar, Danielle Mcmichael, Jonathan M. Cohen, Abirami Manian, Ciaran Harvey, Louise Shaw Primrose, Stefanie Wilson, Declan T. Bradley, Karthik Paranthaman, Stuart Beard, Maria Zambon, Mary Ramsay, Vanessa Saliba, Shamez Ladhani, Christopher Williams

Summary: Enteroviruses commonly cause seasonal childhood infections, with most cases being mild and self-limiting. However, severe disease can occur in neonates, including the rare complication of myocarditis. This article reports on a cluster of 20 severe neonatal enteroviral myocarditis cases caused by coxsackie B viruses in the United Kingdom. Sixteen cases required critical care support and two resulted in death. Enterovirus PCR on whole blood was found to be the most sensitive diagnostic test. The aim of this article is to raise awareness among paediatricians, laboratories, and public health specialists.

EUROSURVEILLANCE (2023)

Article Immunology

A Re-emergence of Subacute Sclerosing Panencephalitis in the United Kingdom

Helen Campbell, Jamie Lopez Bernal, Antoaneta Bukasa, Nick Andrews, Elaine Baker, Polly Maunder, Anne Marie Winstone, Mary Ramsay, Christopher Verity, Kevin Brown

Summary: New cases of pediatric and adult subacute sclerosing panencephalitis between 1996 and 2020 were reported based on an established UK registry, which showed no evidence of under-ascertainment and used a separate pediatric surveillance system. After 15 years without any domestically acquired cases, 3 cases emerged in 2017 following an increase in measles. Modeling indicated that this was consistent with the number of measles notifications, underreporting of laboratory-confirmed measles, or an increased risk of subacute sclerosing panencephalitis.

PEDIATRIC INFECTIOUS DISEASE JOURNAL (2023)

Article Health Care Sciences & Services

Household transmission of COVID-19 cases associated with SARS-CoV-2 delta variant (B.1.617.2): national case-control study

Hester Allen, Amoolya Vusirikala, Joe Flannagan, Katherine A. Twohig, Asad Zaidi, Dimple Chudasama, Theresa Lamagni, Natalie Groves, Charlie Turner, Christopher Rawlinson, Jamie Lopez-Bernal, Ross Harris, Andre Charlett, Gavin Dabrera, Meaghan Kall

Summary: This study indirectly assessed the differences in transmissibility between the SARS-CoV-2 Delta variant and the previously dominant Alpha variant. The results showed that the Delta variant had a higher rate of household transmission, potentially explaining its success in displacing the Alpha variant as the dominant strain in England. Understanding the transmissibility of this variant is important for informing international infection prevention and control policies.

LANCET REGIONAL HEALTH-EUROPE (2022)

Article Medicine, General & Internal

Covid-19 Vaccine Effectiveness against the Omicron (B.1.1.529) Variant

N. Andrews, J. Stowe, F. Kirsebom, S. Toffa, T. Rickeard, E. Gallagher, C. Gower, M. Kall, N. Groves, A-M O'connell, D. Simons, P. B. Blomquist, A. Zaidi, S. Nash, N. Iwani Binti Abdul Aziz, S. Thelwall, G. Dabrera, R. Myers, G. Amirthalingam, S. Gharbia, J. C. Barrett, R. Elson, S. N. Ladhani, N. Ferguson, M. Zambon, C. N. J. Campbell, K. Brown, S. Hopkins, M. Chand, M. Ramsay, J. Lopez Bernal

Summary: A large case-control study in England found that immunity to the Omicron variant was very low and less than that to the Delta variant 20 weeks after the second vaccine dose, regardless of the initial vaccine type. A booster dose of one of the mRNA vaccines improved efficacy to approximately 65%, but protection waned over a 10-week period.

NEW ENGLAND JOURNAL OF MEDICINE (2022)

No Data Available